Evidence supporting the use of: L-Acetyl n-Cysteine
For the health condition: Cystic Fibrosis
Synopsis
Source of validity: Scientific
Rating (out of 5): 3
L-Acetyl n-Cysteine (NAC) is used in the management of cystic fibrosis (CF) primarily due to its mucolytic and antioxidant properties. The rationale is based on the need to reduce the viscosity of pulmonary secretions and to counteract oxidative stress—both significant issues in CF pathology. NAC serves as a precursor to glutathione, an important intracellular antioxidant that is often depleted in CF patients. By replenishing glutathione levels, NAC may help protect lung tissue from oxidative damage.
Historically, mucolytic agents have played a role in CF management to improve airway clearance. NAC can disrupt disulfide bonds in mucus glycoproteins, potentially reducing mucus thickness and facilitating expectoration.
However, clinical evidence supporting the efficacy of oral or inhaled NAC in CF is mixed. Some early studies suggested modest improvements in sputum viscosity and markers of oxidative stress, but larger and more recent randomized controlled trials have not consistently demonstrated clear clinical benefits in terms of lung function or exacerbation rates. Systematic reviews, including Cochrane reviews, generally conclude that while NAC is well-tolerated, there is insufficient high-quality evidence to recommend its routine use in CF, especially as a mucolytic, over other established therapies such as dornase alfa or hypertonic saline.
In summary, the use of NAC in CF is scientifically grounded based on its pharmacological properties, but clinical evidence for significant benefit is limited, leading to only moderate support for its use in this context.
Other health conditions supported by L-Acetyl n-Cysteine
Acquired Immune Deficiency SyndromeAddictions (drugs)
Alzheimer's Disease
Anxiety Disorders
Arthritis
Asthma
Autism
Autoimmune Disorders
Bipolar Mood Disorder
Cancer Treatment (reducing side effects)
Chemotherapy (reducing side effects)
Chronic Obstructive Pulmonary Disorder
Cirrhosis of the Liver
Colitis
Congestive Heart Failure
Cystic Fibrosis
Depression
Diabetes
Emphysema
Fatty Liver Disease
Fibrosis
Free Radical Damage
Gingivitis
Heavy Metal Poisoning
Hepatitis